Real Startups Never, Ever Discount Their Prices

InfoChachkie

Avoid a simple pricing mistake which could sink your startup. Vendors often respond by discounting their prices at the 11th hour, in the hopes a lower price will spur a purchase. Protection – Consider offering “pricing protection” to users who are particularly price-conscious.

Trump Budget Touts Lower Drug Prices, But No Medicare Negotiation

Xconomy

He vowed during last month’s State of the Union speech that drug prices “will come down.” ” Today, his administration’s fiscal 2019 budget proposal laid out what it calls a “comprehensive” strategy to lower drug prices.

Despite Pharma Ties, Some Patient Groups Protest High Drug Prices

Xconomy

For 20 years, Deborah Long (pictured) has been relying on powerful drugs to keep her multiple sclerosis in check. Her out-of-pocket costs were pretty reasonable until two years ago, she says, when she had to switch insurance companies. Her new insurer made her switch to a different drug, Copaxone.

Bio Roundup: Big Approvals, ICER Influence, Drug-Price Pushback & More

Xconomy

We also saw a new biotech emerge in the muggy New York heat, a couple deals for new flu vaccines, and interesting developments in the complicated world of drug pricing. We’ll start the roundup this week with two drug approvals that came late last Friday. Both were landmarks for the companies receiving the nod, Alnylam Pharmaceuticals and Amicus Therapeutics.

Odonate Therapeutics Prices IPO

socalTECH

San Diego-based Odonate Therapeutics , a pharmaceuticals startup focused on chemotherapy drugs, has priced its IPO, saying on Wednesday afternoon that it has priced its IPO at $24.00 per share was on the low end of its initial estimated pricing range of $24.00 per share. The $24.00 to $27.00. The company is selling 6,250,000 shares of its common stock in the offering, which will raise $150M for the company.

Pharmaceutical Price Controls Might Be Closer Than You Think

Xconomy

Amid the hue and cry over the Mylan EpiPen pricing debacle , Hillary Clinton unveiled her “ Plan to Respond to Unjustified Price Hikes for Long-Available Drugs. ” Clinton’s plan calls for “dedicated oversight to protect consumers.” Clinton proposes to combat “unjustified price hikes.”

Amazon Drops Price of Ring Doorbell

L.A. Business Journal

didn’t waste any time dropping the price of Ring Inc.’s from the prior retail price of $149.99. Amazon.com Inc. s video doorbell to $99.99 The announcement came on April 12 at the same time Amazon and Ring officially closed the $1 billion acquisition

Sonos Bumps Pricing In Europe

socalTECH

Santa Barbara-based whole home music system developer Sonos is significantly bumping up the prices of its system in Europe, the company said over the weekend, due to big changes in the U.S. According to Sonos, it has significantly increased its prices of products in Europe, because its existing pricing has "become unsustainable". Sonos outlined a long list of pricing increases , which it said will go into effect July 31st.

Drug Price Watchdog ICER Deems Amgen Migraine Drug “Cost-Effective”

Xconomy

In setting a price thousands of dollars less than expected, Amgen has won over one of the pharmaceutical industry’s fiercest drug price critics. The non-profit Institute for Clinical and Economic Review (ICER) assessed the effectiveness and value of the Amgen (NASDAQ: AMGN ) drug erenumab (Aimovig) and other new migraine drugs, and concluded in an updated report that erenumab offers value to patients in the price range of $3,700 to $5,300 per year.

NantHealth Sets IPO Pricing Range

socalTECH

Culver City-based NantHealth , one of the startups out of billionaire Patrick Soon-Shiong's NantWorks portfolio, has set its IPO pricing range at between $12.50 The next step in the IPO process is the company's roadshow to investors and actual pricing of an IPO. nanthealth nantworks merger acquisition pricing personalized medicine

Sonos Sets Estimated IPO Pricing Range

socalTECH

Santa Barbara-based Sonos , the developer of user-friendly, Internet-connected, whole-home audio systems, set its estimated IPO pricing range on Monday morning, the next step in bringing the company to market. The estimated pricing range is usually set before a company's roadshow to institutional investors, and helps to provide guidance on an ultimate pricing of the IPO, which will occur the evening before the public debut of Sonos.

Tocagen Sets IPO Pricing Range

socalTECH

San Diego-based Tocagen , a clinical stage gene therapy company aiming at treating cancer, has set the pricing range for its IPO. The company said in a filing that it expects to offer 7,250,000 shares of its common stock at between $10.00 and $12.00 per share. The company has applied to list as TOCA on the NASDAQ Global Market. Tocagen's IPO is being underwritten by Leerink Partners, Evercore ISI, and Stifel.

Geni Swizzles Pricing Tiers

socalTECH

Geni has been shuffling its various pricing tiers since August, when the firm started encouraging users to move off its free service to one of its paid tiers. geni family history tree genealogy membership pricing

Geni 169

Scoutfit Takes On Pricing Alerts, Promotions

socalTECH

Looking to score the best price on that gift for the holiday season? A new, Los Angeles startup, Scoutfit , said today that it has launched a new, online shopping service which helps users track discounts and get price alerts on items during the holiday.

BlackLine Software Prices IPO

socalTECH

Woodland Hills-based BlackLine Software , the developer of accounting and financial close software, has priced its IPO, saying late Thursday evening that it will sell 8,600,000 shares of its common stock at $17.00 BlackLine priced at the high range of an already increased estimated IPO range, which was set to $16.00

Helping Consumers Name Their Own Price For Products, With Greentoe

socalTECH

In real life, you can just about bargain a price for anything you want to buy--a car, a house, even that new stereo from your local electronics store. Joe Marrapodi: GreenToe is a name your own price marketplace for products.

Trump Team Outlines Healthcare Agenda—No Mention of Drug Prices

Xconomy

There is no mention of drug pricing or what the administration might do about frequent price increases, such as Mylan’s EpiPen practice, that critics say are unsubstantiated and unethical. During the campaign, Trump’s official platform called for a change to let Medicare negotiate drug prices and for the re-importation of lower cost drugs from abroad—ideas that swim upstream against typical GOP positions.

Mobile Roadie Swizzles Pricing

socalTECH

Mobile software developer Mobile Roadie looks to be in the midst of an interesting transition, saying late last week that it is increasing its pricing, to "more closely match the value we are able to offer." Details of those pricing changes were not announced by the company. Mobile Roadie did say it would not be changing pricing for existing customers of the product. mobile roadie pricing development

Startup Pricing: Are You Selling A Giffen Product?

InfoChachkie

In his premier film appearance in the blaxploitation send-up “I’m Gonna Git You Sucka,” Chris Rock inadvertently addresses a key pricing challenge faced by most entrepreneurs. Watch this 93-second clip and see if you can identify the pricing pitfall addressed in this humorous snippet.

Obalon Sets IPO Pricing Range

socalTECH

Carlsbad-based Obalon Therapeutics , which is developing a balloon-based medical device for assisting in weight loss, has set the estimated initial IPO pricing range for its public offering, saying it now expects an initial public offering at between $14.00 if it prices at the high end of its estimated range.

The Trade Desk Prices IPO, To Hit NASDAQ Today

socalTECH

Ventura-based The Trade Desk , which operates an online advertising exchange, priced its IPO late Tuesday evening, saying that it will sell 4,666,677 shares of its Class A common stock at $18.00 The Trade Desk priced at the high end of an already increased estimated IPO range, which had been upped to between $16.00 trade desk pricing merger acquisition advertising exchange market marketplace accelerator incubator nasdaq global

Ambrx Sets IPO Pricing Range

socalTECH

La Jolla-based biopharmaceuticals developer Ambrx has set its initial estimated pricing range for its IPO, saying in a filing this morning that it expects to price its IPO at between $12.00 ambrx pricing merger acquisition nasdaq ambx exit biotech lifescience biopharma biopharmaceuticals protein antibody

Novartis Wins Historic FDA Nod, Prices CAR-T For Leukemia at $475,000

Xconomy

Ahead of schedule, Novartis has received the first-ever approval of a genetically modified living cell therapy called CAR-T, which uses a cancer patient’s own immune cells as the medicine.

Regeneron to Slash Price of Cholesterol Drug After Showing it Saved Lives

Xconomy

And in an unusual move, Regeneron—based on input from the nonprofit drug-pricing watchdog, the Institute for Clinical and Economic Review (ICER)—vows to cut the cost of the drug if it can get certain concessions from insurers.

Bio Roundup: Drug Prices, CRISPR Caveats, Rubius IPO Pop & More

Xconomy

After nearly two years of all smoke, no fire around President Trump’s promise to curtail drug prices, there’s finally some glimmer of action. Pfizer said last week it would halt its price hikes, and Novartis and Merck took similar actions this week. But we still don’t know the details of the administration’s drug-pricing policy, if there is one beyond the blueprint released in May.

How to Lower Drug Prices, Improve Care, and Save Pharma

Xconomy

I recently received a note from a longtime friend who questioned me on the issue of pharma pricing. I answered with the always-reliable alleviating-the-scourge-of-disease-through-the-miracle-of-modern-medicine defense of “free-market pricing.”

SaaS Subcriptions Are Great – TranSaaSional Pricing Is Better

InfoChachkie

Software as a service (SaaS) is a popular business model because it facilitates the delivery of incremental value to customers, while allowing the vendor to adjust their prices over time. However, such price increases generally occur after new utility has been provided to the customers.

SaaS 221

Aerie Pharmaceuticals Prices IPO

socalTECH

Aerie Pharmaceuticals , which develops therapies for treating glaucoma and other eye diseases, has priced its IPO, saying this morning that it is offering up 6,720,000 share os its common stock at $10.00

Nimble Cuts Pricing For Nonprofits

socalTECH

contact track sales management relationship customer nonprofit pricing nimble Santa Monica-based customer relationship management (CRM) software developer Nimble is looking to bolster its customer base in the nonprofit sector, saying that it has started to offer a 30 percent discount on its service to nonprofits, for life.

Ambit Biosciences Prices IPO

socalTECH

San Diego-based Ambit Biosciences has priced its IPO, saying that it is offering up 8,125,000 shares of its common stock at $8.00 Ambit priced well below its estimated initial public offering range, which had been set at between $13.00

Bio Roundup: ASCO Abstracts, Migraine Drug Prices & “Blueprint” Fallout

Xconomy

There’s nothing abstract about a 20 percent jump in a company’s stock price. We also have the latest on the Trump administration’s finger-wagging attempts to rein in drug prices; a raft. But yeah, that happened to Loxo Oncology when it released data previews for its American Society for Clinical Oncology presentations; the meeting starts in two weeks in Chicago.

Report: Price For Faraday Future's FF91 Nearly $300,000

socalTECH

Los Angeles-based electric car maker Faraday Future rolled outs its first production vehicle, the FF91, at CES earlier this month, but had not announced pricing. However, a new report says that LeEco CEO Jia Yueting has said that the new FF91 will cost "less than $300,000"--a staggeringly high price tag for an electric vehicle. Faraday Future has not officially announced the expected pricing for the vehicle. faraday future ff91 electric automobile pricing cleantech

Senators Grill HHS’s Azar on Drug Price Cuts That Have Yet to Come

Xconomy

When President Trump signed legislation last month allowing seriously ill patients the “right to try” unapproved drugs without FDA oversight, he voiced a bold prediction: Within two weeks, he said, drug companies would announce “voluntary massive drops in prices.”

Dear Tom Price: Bundled Payments Help Patients and Reduce Costs

Xconomy

With all the talk of repealing Barack Obama’s Affordable Care Act (ACA), people have been taking a closer look at what the law has done for our healthcare system. It turns out the ACA is about a lot more than the problematic healthcare marketplaces.

Sonos Boosts UK Pricing By 25 Percent Due To Brexit

socalTECH

Santa Barbara-based whole home music system developer Sonos is boosting its prices in the United Kingdom by 25 percent, due to "a significant change on the US Dollar to GBP exchange rate." The company said that, starting on February 23rd, it will be boosting its prices in the UK , because its existing pricing has "become unsustainable". sonos pricing brexit politics sound speakers music system